Combinations of sapacitabine or CNFAC with DNA methyltransferase inhibitors such as decitabine and procaine

Details for Australian Patent Application No. 2009259136 (hide)

Owner Cyclacel Limited

Inventors Fleming, Ian Neil; Green, Simon Richard; Mackay, Ruth

Agent FB Rice

Pub. Number AU-A-2009259136

PCT Pub. Number WO2009/150405

Priority 0906696.0 17.04.09 GB; 0810552.0 09.06.08 GB

Filing date 5 June 2009

Wipo publication date 17 December 2009

International Classifications

A61K 31/245 (2006.01)

A61K 31/353 (2006.01)

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/706 (2006.01)

A61K 31/7068 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/150405 Priority application(s): WO2009/150405

6 January 2011 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Cyclacel Limited., Application No. 2009259136, under INID (54) correct the title to read Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009259138-Motor assembly

2009259124-Changing the temperature of a thermal load